Individuals with High Social Anhedonia but not Schizophrenia Exhibited Altered Empathy in Daily Life.

Schizophr Bull

Neuropsychology and Applied Cognitive Neuroscience Laboratory, State Key Laboratory of Cognitive Science and Mental Health, Institute of Psychology, Chinese Academy of Sciences, 16 Lincui Road, Chaoyang District, Beijing 100101, China.

Published: August 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background And Hypothesis: Despite empathic abnormalities exhibited in both clinical and subclinical samples of schizophrenia (SCZ) in the laboratory, understanding of their empathy in the real world remains limited. This study applied the experience sampling method (ESM) to investigate empathy in people with SCZ and high social anhedonia (SocAnh), as well as its associations with social pleasure and emotional states in daily life.

Study Design: Thirty-one participants with SCZ, 31 individuals with high SocAnh, and 32 healthy controls completed a 7-day ESM survey (10 surveys per day) to assess empathy, social pleasure, and emotional states in daily life. The empathic accuracy task was used to measure empathy accuracy (EA) in the laboratory. Multilevel regression models were estimated to examine group differences of the ESM variables and their associations.

Study Results: Compared to controls, people with SCZ showed lower EA but comparable cognitive and affective empathy in daily life, whereas Individuals with high SocAnh exhibited similar EA but lower affective empathy in daily life. Positive association between social pleasure and empathy was found across 3 groups. Empathy for positive emotions predicted increased positive emotional states in individuals with high SocAnh and controls, but not in people with SCZ. Positive emotional states predicted greater empathy in individuals with high SocAnh, which was not observed in the other 2 groups.

Conclusions: Our findings revealed altered empathy in daily life among people at-risk for SCZ but not in clinical patients, shedding light on a better understanding of social cognitive changes in SCZ spectrum.

Download full-text PDF

Source
http://dx.doi.org/10.1093/schbul/sbaf136DOI Listing

Publication Analysis

Top Keywords

individuals high
20
daily life
20
empathy daily
16
emotional states
16
high socanh
16
people scz
12
social pleasure
12
empathy
11
high social
8
social anhedonia
8

Similar Publications

Background: Chest radiography is often performed preoperatively as a common diagnostic tool. However, chest radiography carries the risk of radiation exposure. Given the uncertainty surrounding the utility of preoperative chest radiographs, physicians require systematically developed recommendations.

View Article and Find Full Text PDF

Autoimmune nodopathies: emerging insights and clinical implications.

Curr Opin Neurol

October 2025

Neuromuscular Diseases Unit, Department of Neurology, IR SANT PAU, Hospital de la Santa Creu i Sant Pau, CIBERER, Barcelona, Spain.

Purpose Of Review: Autoimmune nodopathies (AN) are a recognized distinct group of immune-mediated peripheral neuropathies with unique immunopathological features and therapeutic implications. This review synthesizes recent advances in their pathogenesis, diagnosis, and management, which have refined their clinical classification and informed targeted treatment strategies.

Recent Findings: AN are characterized by autoantibodies targeting surface proteins in the nodal-paranodal area (anti-contactin-1, anti-contactin-associated protein 1, anti-neurofascin-155, anti-pan-neurofascin), predominantly of IgG4 subclass.

View Article and Find Full Text PDF

Background: Early identification of pathological α-synuclein deposition (αSynD) may improve understanding of Lewy body disorder (LBD) progression and enable timely disease-modifying treatments.

Objectives: We investigated αSynD using a seed amplification assay and assessed prodromal LBD symptoms in individuals with idiopathic olfactory dysfunction (iOD).

Methods: In this cross-sectional, case-control study, we included iOD participants and normosmic healthy controls (HC) aged 55 to 75 years without diagnoses of dementia with Lewy bodies, Parkinson's disease (PD), or other major neurological disorders.

View Article and Find Full Text PDF

Early-stage cancer diagnosis is considered a grand challenge, and even though advanced analytical assays have been established through molecular biology techniques, there are still clinical limitations. For example, low concentration of target biomarkers at early stages of cancer, background values from the healthy cells, individual variation, and factors like DNA mutations, remain the limiting factor in early cancer detection. Volatile organic compound (VOC) biomarkers in exhaled breath are produced during cancer cell metabolism, and therefore may present a promising way to diagnose cancer at the early stage since they can be detected both rapidly and non-invasively.

View Article and Find Full Text PDF

Minimal Clinically Important Difference of the Scale for the Assessment and Rating of Ataxia.

Mov Disord Clin Pract

September 2025

Department of Physical Medicine and Rehabilitation, College of Physicians and Surgeons, Columbia University Medical Center, New York, New York, USA.

Background: The Scale for the Assessment and Rating of Ataxia (SARA) is the most used outcome measure in clinical trials for cerebellar ataxias. The minimal clinically important difference (MCID), a parameter used to assess meaningful change, is not clearly defined.

Objective: To help define MCID for SARA.

View Article and Find Full Text PDF